Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group (Q102063741)
Jump to navigation
Jump to search
scientific article published on 16 November 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group |
scientific article published on 16 November 2020 |
Statements
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group (English)
Martin Bornhäuser
Eva-Maria Wagner-Drouet
Salem Ajib
Gesine Bug
Martina Crysandt
Sabine Dressler
Andreas Hausmann
Daniela Heidenreich
Klaus Hirschbühl
Matthias Hoepting
Edgar Jost
Jennifer Kaivers
Stefan Klein
Michael Koldehoff
Lambros Kordelas
Oliver Kriege
Lutz P Müller
Christina Rautenberg
Judith Schaffrath
Christoph Schmid
Daniel Wolff
Rainer Haas
Thomas Schroeder
Guido Kobbe
German Cooperative Transplant Study Group
16 November 2020